SFM
KZR

Sphera Funds Management’s Kezar Life Sciences KZR Stock Holding History

Sphera Funds Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-58,539
Closed -$268K – 124
2025
Q2 		$268K Sell
58,539
-49,934
-46% -$214K 0.06% 102
2025
Q1 		$529K Hold
108,473
– – 0.12% 104
2024
Q4 		$729K Buy
108,473
+87,956
+429% +$655K 0.13% 98
2024
Q3 		$1.59M Sell
20,517
-184,651
-90% -$1.11M 0.25% 90
2024
Q2 		$1.23M Hold
205,168
– – 0.17% 102
2024
Q1 		$1.85M Hold
205,168
– – 0.26% 79
2023
Q4 		$1.94M Hold
205,168
– – 0.31% 74
2023
Q3 		$2.44M Buy
205,168
+6,345
+3% +$112K 0.44% 64
2023
Q2 		$4.87M Buy
198,823
+10,000
+5% +$260K 0.76% 52
2023
Q1 		$5.91M Buy
188,823
+58,305
+45% +$3.37M 0.99% 33
2022
Q4 		$9.19M Buy
130,518
+5,937
+5% +$440K 1.97% 14
2022
Q3 		$10.7M Buy
124,581
+94,616
+316% +$9.19M 1.49% 16
2022
Q2 		$2.48M Buy
29,965
+11,205
+60% +$988K 0.27% 38
2022
Q1 		$3.12M Sell
18,760
-14,969
-44% -$2.15M 0.44% 48
2021
Q4 		$5.64M Buy
+33,729
New +$3.81M 0.62% 52
2019
Q3 		– Sell
-6,920
Closed -$534K – 91
2019
Q2 		$534K Buy
+6,920
New +$1.08M 0.07% 82
2019
Q1 		– Sell
-2,000
Closed -$472K – 114
2018
Q4 		$472K Sell
2,000
-19,200
-91% -$4.69M 0.05% 94
2018
Q3 		$4.54M Sell
21,200
-1,590
-7% -$278K 0.52% 53
2018
Q2 		$3.94M Buy
+22,790
New +$3.98M 0.54% 55

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Sphera Funds Management's KZR Position: Q3 2025 in Review

Sphera Funds Management sold out of Kezar Life Sciences (KZR) in Q3 2025, closing a stake of 58,539 shares — an estimated $268K sold.

Sphera Funds Management first reported a position in KZR in Q2 2018 and held it in 19 quarters. The position peaked at $10.7M in Q3 2022. 39 funds tracked by Wall St. Rank hold KZR as of Q3 2025.

  • Sphera Funds Management reported no remaining Kezar Life Sciences position as of Q3 2025 after selling out during the quarter.
  • Sphera Funds Management sold 58,539 Kezar Life Sciences shares in Q3 2025, an estimated $268K.
  • Sphera Funds Management first reported a position in Kezar Life Sciences in Q2 2018 and held it in 19 quarters.
  • Sphera Funds Management's Kezar Life Sciences position peaked at $10.7M in Q3 2022.
  • 39 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2025.

Based on Sphera Funds Management's 13F filing for Q3 2025, filed 14 Nov 2025.